IBDT — iShares iBonds Dec 2028 Term Corporate ETF
Data updated: 2026-06-25
IBDT — iShares iBonds Dec 2028 Term Corporate ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Short Corporate Bond · $3.83B AUM · 0.10% expense ratio · 4.5% 1-yr return. From SEC regulatory filings.
IBDT Fund Overview
IBDT — iShares iBonds Dec 2028 Term Corporate ETF is a US ETF managed by iSHARES TRUST, categorised as Short Corporate Bond. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: iSHARES TRUST
- Category: Short Corporate Bond
- Assets under management: $3.83B
- 1-year return: 4.5%
- Ticker: IBDT
- SEC CIK: 0001100663
- SEC series ID: S000063041
- Share class ID: C000204503
IBDT Holdings
Top 10 holdings of iShares iBonds Dec 2028 Term Corporate ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| BlackRock Funds III | 3.46% |
| Cvs Health Corp. | 0.89% |
| Pfizer Investment Enter | 0.70% |
| Amgen, Inc. | 0.69% |
| Cigna Group/the | 0.67% |
| Aercap Ireland Cap/globa | 0.64% |
| Blackrock Cash Funds Treasury Sl Agency Shares | 0.60% |
| Salesforce, Inc. | 0.55% |
| Rtx Corp. | 0.54% |
| Morgan Stanley | 0.54% |
IBDT Portfolio Allocation
Asset-class allocation of iShares iBonds Dec 2028 Term Corporate ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Fixed Income | 98.4% |
| Cash & Equivalents | 4.1% |
IBDT Performance
Total returns for IBDT (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 0.6% |
| 1 year | 4.5% |
| 3 years (annualised) | 5.1% |
| 5 years (annualised) | 1.5% |
IBDT Risk Information
Risk metrics for IBDT, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 1.4%
IBDT Costs and Fees
IBDT costs about $10 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.10%
- Gross expense ratio: 0.10%
- Portfolio turnover: 7%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
IBDT Cashflows
Over the 12 months to 2026-04, iShares iBonds Dec 2028 Term Corporate ETF had net inflows of $1.04B, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $12.65M |
| 2026-03 | $63.34M |
| 2026-02 | $61.15M |
| 2026-01 | $150.24M |
| 2025-12 | $275.69M |
| 2025-11 | $94.14M |
IBDT Debt Constituents
Largest debt holdings of iShares iBonds Dec 2028 Term Corporate ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Cvs Health Corp. | 0.89% |
| Pfizer Investment Enter | 0.70% |
| Amgen, Inc. | 0.69% |
| Cigna Group/the | 0.67% |
| Aercap Ireland Cap/globa | 0.64% |
| Salesforce, Inc. | 0.55% |
| Rtx Corp. | 0.54% |
| Morgan Stanley | 0.54% |
| Comcast Corp. | 0.54% |
| Verizon Communications | 0.49% |
IBDT Prospectus and SEC Filings
Official iShares iBonds Dec 2028 Term Corporate ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Short Corporate Bond funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.